INS and Alzheimer disease: Using high-throughput total- and phospho-proteomics combined with bioinformatics analysis, we characterize the molecular and signaling cascades that may impact AD progression, and which include cytoskeletal signaling, insulin signaling and resistance, cell cycle re-entry, and consequent neuronal cell death.